Mylan Laboratories, Inc. (NASDAQ:MYL)
CAPS Rating:
The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
Recs
Just got FDA approval to market generic versions of Flomax and Desoxin